CD274 and diffuse large B-cell lymphoma: But DLBCL patients with co-expression of PD-L1 and p-AKT had poorer 3 years OS (P=0.002) and 5 years OS (P=0.014) compared to patients with both negative expression of PD-L1 and p-AKT (Table 4).